Chesapeake Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,386
| Closed | -$781K | – | 165 |
|
|
2022
Q1 | $781K | Buy |
1,386
+5
| +0.4% | +$2.82K | 0.28% | 88 |
|
|
2021
Q4 | $1.04M | Buy |
1,381
+75
| +6% | +$56.6K | 0.35% | 73 |
|
|
2021
Q3 | $974K | Sell |
1,306
-104
| -7% | -$77.6K | 0.35% | 70 |
|
|
2021
Q2 | $909K | Sell |
1,410
-53
| -4% | -$34.2K | 0.29% | 85 |
|
|
2021
Q1 | $836K | Buy |
1,463
+297
| +25% | +$170K | 0.28% | 91 |
|
|
2020
Q4 | $680K | Buy |
1,166
+52
| +5% | +$30.3K | 0.23% | 101 |
|
|
2020
Q3 | $574K | Buy |
1,114
+236
| +27% | +$122K | 0.21% | 109 |
|
|
2020
Q2 | $396K | Buy |
+878
| New | +$396K | 0.16% | 136 |
|